NEU 2.37% $19.39 neuren pharmaceuticals limited

I suspect this is where a new way of doing things, which is...

  1. 632 Posts.
    lightbulb Created with Sketch. 434
    I suspect this is where a new way of doing things, which is already happening in oncology and other areas, called precision medicine could come into play.

    So rather than defining disease by its phenotypic/syndromic features, it is defined by its molecular features. What this would mean, is that instead of having to do a separate trial for each of 100+ syndromes, you just do one trial incorporating any patient who has a genetic alteration resulting in IGF-1 and pERK dysregulation for example, or whatever the molecular target of 2591 is deemed to be.

    Now this is all more easily said than done and is a nascent field, but it is already happening and with the exponential advances in the field of genomics I think provides a way forward for phenotypically heterogeneous disease.
    Last edited by turbo: 21/04/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.39
Change
-0.470(2.37%)
Mkt cap ! $2.478B
Open High Low Value Volume
$19.70 $19.77 $19.28 $10.38M 534.0K

Buyers (Bids)

No. Vol. Price($)
3 2680 $19.35
 

Sellers (Offers)

Price($) Vol. No.
$19.41 362 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.